Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Epub 2013 Feb 11
InChi: InChI=1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31
Cinnamomum verum ingredient 2-methoxycinnamaldehyde: a new antiproliferative drug targeting topoisomerase I and II in human lung squamous cell carcinoma NCI-H520 cells
25(12):1883-90
¹⁵]hexadeca-1(15)
(R)-Elagolix Size:Contact [email protected] for quotation Epub 2013 Feb 11Elagolix is a highly potent, selective, orally active, short duration, non peptide antagonist of the gonadotropin releasing hormone receptor (GnRHR) (KD = 54 pM). Target: GnRHin vitro: Elagolix is a short acting, nonpeptide, GnRH antagonist, administered orally, that unlike injectable depot GnRH agonists and antagonists, produces a dose dependent suppression of ovarian estrogen production, that is, from partial suppression at lower doses to full
US$ 148.00
US$ 174.00
US$ 149.50
US$ 136.50
US$ 147.50
US$ 151.50
US$ 152.00
US$ 161.00
US$ 69.99